HEALTHXNSEHealth X Platform LimitedHighNeutral
Announced Fri, 15 May · 12:31 IST

Health X Platform Limited has informed the Exchange about Intimation under Regulation 30 of SEBI (LODR) Reg, 2015 Completion of the transfer of the entire equity stake of Mitsubishi Corporation held in Sastasundar Healthbuddy Limited, a material subsidiary of Health X Platform Limited (Company), to Envision India Fund.

Ownership Changes View source PDF

HEALTHX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.4%1-day move
₹289.75
prior close
₹287.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0-0.7+2.4-2.9-1.6-2.0-0.1+7.3+2.4+3.5+14.6
Up moveDown movePending
AI summary

Health X Platform Limited has announced the completion of a stake sale in its material subsidiary Sastasundar Healthbuddy Limited. Mitsubishi Corporation sold its entire holding of 10,13,766 equity shares (4.68% stake) to Envision India Fund. The transaction was completed on May 12, 2026. Following this transfer, Mitsubishi Corporation has ceased to be a shareholder of Sastasundar Healthbuddy Limited. The board of the subsidiary took note of this transfer on May 15, 2026. This follows an earlier disclosure dated February 25, 2026 regarding the execution of a Share Purchase Agreement.

Likely market impact

This is a change in the shareholding pattern of the company's material subsidiary. While the 4.68% stake sale by Mitsubishi Corporation does not directly impact the parent company's shareholding, it reflects a strategic restructuring at the subsidiary level with a new investor (Envision India Fund) entering.